Cargando…
Post-COVID-19 Hyperglycemia: A Concern in Selection of Therapeutic Regimens
Autor principal: | Negahdaripour, Manica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288489/ https://www.ncbi.nlm.nih.gov/pubmed/34305235 http://dx.doi.org/10.30476/ijms.2021.47666 |
Ejemplares similares
-
The Rise and Fall in Therapeutic Candidates for COVID-19
por: Negahdaripour, Manica
Publicado: (2020) -
A World of Changes: The Inheritance of COVID-19
por: Negahdaripour, Manica
Publicado: (2020) -
COVID-19 Vaccine Global Access Is an Urgency
por: Negahdaripour, Manica
Publicado: (2021) -
The Battle Against COVID-19: Where Do We Stand Now?
por: Negahdaripour, Manica
Publicado: (2020) -
Evaluation of the Costs and Outcomes of COVID-19 Therapeutic Regimens in Hospitalized Patients in Shiraz
por: Behboodikhah, Hooman, et al.
Publicado: (2022)